These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L, Ahrén B, Edgren G, Degerman E. Endocrinology; 2005 Feb 03; 146(2):744-50. PubMed ID: 15514088 [Abstract] [Full Text] [Related]
5. Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei. Nomura M, Ueta Y, Serino R, Yamamoto Y, Shibuya I, Yamashita H. Neuroendocrinology; 1999 Mar 03; 69(3):167-80. PubMed ID: 10087449 [Abstract] [Full Text] [Related]
6. Possible involvement of vasoactive intestinal polypeptide in the central stimulating action of pituitary adenylate cyclase-activating polypeptide on prolactin secretion in the rat. Yamauchi K, Murakami Y, Nishiki M, Tanaka J, Koshimura K, Kato Y. Neurosci Lett; 1995 Apr 14; 189(2):131-4. PubMed ID: 7609919 [Abstract] [Full Text] [Related]
7. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L. Endocrinology; 1995 May 14; 136(5):2088-98. PubMed ID: 7720658 [Abstract] [Full Text] [Related]
8. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate. Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC. Endocrinology; 1996 Jul 14; 137(7):2815-22. PubMed ID: 8770902 [Abstract] [Full Text] [Related]
10. Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion. Lutz-Bucher B, Monnier D, Koch B. Neuroendocrinology; 1996 Aug 14; 64(2):153-61. PubMed ID: 8857610 [Abstract] [Full Text] [Related]
19. Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter. Hernández M, Barahona MV, Recio P, Rivera L, Benedito S, Martínez AC, García-Sacristán A, Orensanz LM, Prieto D. Br J Pharmacol; 2004 Jan 12; 141(1):123-31. PubMed ID: 14662737 [Abstract] [Full Text] [Related]
20. Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP. Bredow S, Kacsóh B, Obál F, Fang J, Krueger JM. Brain Res; 1994 Oct 17; 660(2):301-8. PubMed ID: 7820699 [Abstract] [Full Text] [Related] Page: [Next] [New Search]